End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30,400 KRW | -0.65% | +4.83% | -24.47% |
2023 | Invex Therapeutics, Peptron End Collaboration, Manufacturing Deal | MT |
2023 | Tranche Update on Peptron, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
Sales 2022 | 5.81B 4.28M 5.88M | Sales 2023 | 3.34B 2.46M 3.38M | Capitalization | 830B 612M 840M |
---|---|---|---|---|---|
Net income 2022 | -15.06B -11.1M -15.24M | Net income 2023 | -15.92B -11.73M -16.11M | EV / Sales 2022 | 25.8 x |
Net cash position 2022 | 8.02B 5.91M 8.11M | Net Debt 2023 | 4.15B 3.06M 4.2M | EV / Sales 2023 | 250 x |
P/E ratio 2022 |
-10.5
x | P/E ratio 2023 |
-52
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.67% |
1 day | -0.65% | ||
1 week | +4.83% | ||
Current month | +4.83% | ||
1 month | +18.75% | ||
3 months | +34.81% | ||
6 months | -1.78% | ||
Current year | -24.47% |
Managers | Title | Age | Since |
---|---|---|---|
Min-Ho Song
CEO | Chief Executive Officer | 63 | 21-03-29 |
Ho-Il Choi
CEO | Chief Executive Officer | 58 | 97-11-20 |
Seung-Gu Jang
DFI | Director of Finance/CFO | 58 | 99-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ho-Il Choi
CEO | Chief Executive Officer | 58 | 97-11-20 |
Seung-Gu Jang
DFI | Director of Finance/CFO | 58 | 99-06-30 |
Young-Go Jung
BRD | Director/Board Member | 49 | 14-03-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +3.53% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 30,400 | -0.65% | 215,303 |
24-05-03 | 30,600 | +0.99% | 666,430 |
24-05-02 | 30,300 | +4.48% | 945,600 |
24-04-30 | 29,000 | +2.65% | 379,654 |
End-of-day quote Korea S.E., May 06, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-24.47% | 465M | |
+10.44% | 106B | |
+0.82% | 104B | |
+6.72% | 23.25B | |
-13.89% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.98% | 16.99B | |
+8.67% | 14.26B | |
+41.08% | 12.76B |
- Stock Market
- Equities
- A087010 Stock